Opthea Limited - ADR Stock price
Is Opthea Limited - ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,102 stocks worldwide.
Key metrics
Opthea Limited - ADR Stock Analysis
Analyst Opinions
7 Analysts have issued a Opthea Limited - ADR forecast:
Analyst Opinions
7 Analysts have issued a Opthea Limited - ADR forecast:
Don't miss a Thing! We will send you all news about Opthea Limited - ADR directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Opthea Limited - ADR Stock News
Company Profile
Opthea Ltd. is a clinical stage biopharmaceutical company that engages in the development of biological therapeutics for the treatment of progressive retinal diseases. It targets to treat neovascular age-related macular degeneration (wet AMD) and diabetic macular edema, which causes visual impairment among elderly and diabetic patients. The company was founded on October 17, 1984 and is headquartered in South Yarra, Australia.
| Head office | Australia |
| CEO | Frédéric Guerard |
| Employees | 33 |
| Founded | 1984 |
| Website | opthea.com |


